Edition:
United States

People: Vitrolife AB (VITRO.BE)

VITRO.BE on Berlin Stock Exchange

45.59EUR
24 Feb 2017
Change (% chg)

€0.12 (+0.26%)
Prev Close
€45.47
Open
€45.47
Day's High
€46.82
Day's Low
€45.10
Volume
164
Avg. Vol
18
52-wk High
€58.02
52-wk Low
€32.26

Axelsson, Thomas 

Mr. Thomas Axelsson has served as Chief Executive Officer (CEO) of Vitrolife AB since November 17, 2011. He was, among other things, CEO of Stille and Artema. Currently, he is Member of the Board of Directors at MedCap AB. He has also been Chairman of the Board of Directors at SBL Vaccin AB, Neoventa Medical AB, Dipylon Medical AB (previously CMA Microdialysis AB) and Airsonett AB, among others. He was also Business Area Manager at Baxter. He holds a Master of Science degree.

Basic Compensation

Total Annual Compensation, SEK 4,496,000
Restricted Stock Awards, SEK --
Long-Term Incentive Plans, SEK --
All Other, SEK --
Fiscal Year Total, SEK 4,496,000

Options Compensation

  Quantity Market Value
Exercisable -- --
Unexercisable -- --
Exercised -- --